Results 181 to 190 of about 51,654 (292)

Biological aspects of radiation and drug-eluting stents for the prevention of restenosis

open access: bronze, 2004
Jürgen Sindermann   +4 more
openalex   +1 more source

843-5 Drug-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of simple versus complex-strategy approach

open access: bronze, 2004
Manuel Pan   +10 more
openalex   +1 more source

1044-53 Full metal jacket in the drug-eluting stent era: In-hospital and 30-day outcome

open access: bronze, 2004
Dejan Orlić   +10 more
openalex   +1 more source

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results

open access: yesMedical Devices: Evidence and Research, 2014
Guillaume Schurtz,1,2 Cédric Delhaye,1 Christopher Hurt,1,2 Henri Thieuleux,1,2 Gilles Lemesle1–3 1Centre Hémodynamique et Unité des Soins Intensifs de Cardiologie, Hôpital Cardiologique, Centre Hospitalier Ré ...
Schurtz G   +4 more
doaj  

1024-53 Drug-eluting stents for coronary bifurcations: Bench-top insights into the “crush” technique

open access: bronze, 2004
John A. Ormiston   +6 more
openalex   +1 more source

Drug-eluting stents : Insights into safety and indications

open access: yesAnnals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj  

1121-60 Sirolimus drug-eluting stent for the treatment of in-stent restenosis (I-SR) with a clinical and angiographical follow-up over six months

open access: bronze, 2004
Christian Maikowski   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy